Supplementary Materials

Published: 10 September 2021| Version 2 | DOI: 10.17632/bw7pvrhtmx.2
Contributor:
Jinhua Xu

Description

Supplementary Materials for "A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study Evaluating Efficacy and Safety of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis"

Files